RT Journal Article
SR Electronic
T1 Timeliness of U.S. mortality data releases during the COVID-19 pandemic: delays are associated with electronic death registration system and elevated weekly mortality
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.07.21249401
DO 10.1101/2021.01.07.21249401
A1 Rosenbaum, Janet
A1 Stillo, Marco
A1 Graves, Nathaniel
A1 Rivera, Roberto
YR 2021
UL http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249401.abstract
AB All-cause mortality counts allow public health authorities to identify populations experiencing excess deaths from pandemics, natural disasters, and other emergencies. Further, delays in mortality reporting may contribute to misinformation because death counts take weeks to become accurate. We estimate the timeliness of all-cause mortality releases during the Covid-19 pandemic, and identify potential reasons for reporting delays, using 35 weeks of provisional mortality counts between April 3 and December 4, 2020 for 52 states/jurisdictions. On average, states’ mortality counts are delayed by 5.6 weeks (standard deviation 1.74), with a range of 8.8 weeks between the fastest state and the slowest state. States that hadn’t adopted the electronic death registration system were about 4 weeks slower, and 100 additional weekly deaths per million were associated with 0.4 weeks delays, but the residual standard deviation was 0.9 weeks, suggesting other sources of delay. Disaster planning should include improving the timeliness of mortality data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received to support this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is an analysis of publicly available data from United States federal sources in broad categories such that individuals cannot be identified, so it is not human subjects research and is exempt from requiring human subjects board review.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have made the raw data and code publicly available. https://github.com/GreenGrape80/allcausemortality/